Ki‐67 LI grading has been proposed for neuroendocrine tumors (grade 1: ≤ 2%, grade 2: 3–20%, grade 3: ≥ 20%) using the World Health Organization criteria [72, 73]. Here, MKI67 is linked to neuroendocrine neoplasm.